Europe Cancer Vaccines Market Research Report Forecast 2017 to 2022

December 2017 | 138 pages | ID: EF10B9EF1C8EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Cancer Vaccines Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Cancer Vaccines industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Cancer Vaccines market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

Europe Cancer Vaccines Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Dendreon
GlaxoSmithKline
Merck
Sanofi
Vaccinogen
Vaxon Biotech
Vical
Aduro BioTech
Advantagene

Europe Cancer Vaccines Market Analysis by Product:

• Type 1
• Type 2
• Type 3

Europe Cancer Vaccines Market Analysis by Application:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 CANCER VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Vaccines
1.2 Classification of Cancer Vaccines
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Cancer Vaccines
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Cancer Vaccines Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Cancer Vaccines (2012-2022)
  1.5.1 Europe Cancer Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 Europe Cancer Vaccines Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON CANCER VACCINES INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 CANCER VACCINES MANUFACTURING COST ANALYSIS

3.1 Cancer Vaccines Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Cancer Vaccines

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Cancer Vaccines Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE CANCER VACCINES MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Cancer Vaccines Market Competition by Manufacturers
  5.1.1 Europe Cancer Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Cancer Vaccines Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Cancer Vaccines (Volume and Value) by Type
  5.2.1 Europe Cancer Vaccines Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Cancer Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Europe Cancer Vaccines (Volume and Value) by Countries
  5.3.1 Europe Cancer Vaccines Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Cancer Vaccines Revenue and Market Share by Countries (2012-2017)
5.4 Europe Cancer Vaccines (Volume) by Application

6 GERMANY CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Cancer Vaccines Sales and Value (2012-2017)
  6.1.1 Germany Cancer Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 Germany Cancer Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Cancer Vaccines Sales Price Trend (2012-2017)
6.2 Germany Cancer Vaccines Sales and Market Share by Manufacturers
6.3 Germany Cancer Vaccines Sales and Market Share by Type
6.4 Germany Cancer Vaccines Sales and Market Share by Application

7 FRANCE CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 France Cancer Vaccines Sales and Value (2012-2017)
  7.1.1 France Cancer Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 France Cancer Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 France Cancer Vaccines Sales Price Trend (2012-2017)
7.2 France Cancer Vaccines Sales and Market Share by Manufacturers
7.3 France Cancer Vaccines Sales and Market Share by Type
7.4 France Cancer Vaccines Sales and Market Share by Application

8 UK CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 UK Cancer Vaccines Sales and Value (2012-2017)
  8.1.1 UK Cancer Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 UK Cancer Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 UK Cancer Vaccines Sales Price Trend (2012-2017)
8.2 UK Cancer Vaccines Sales and Market Share by Manufacturers
8.3 UK Cancer Vaccines Sales and Market Share by Type
8.4 UK Cancer Vaccines Sales and Market Share by Application

9 RUSSIA CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Cancer Vaccines Sales and Value (2012-2017)
  9.1.1 Russia Cancer Vaccines Sales and Growth Rate (2012-2017)
  9.1.2 Russia Cancer Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Cancer Vaccines Sales Price Trend (2012-2017)
9.2 Russia Cancer Vaccines Sales and Market Share by Manufacturers
9.3 Russia Cancer Vaccines Sales and Market Share by Type
9.4 Russia Cancer Vaccines Sales and Market Share by Application

10 ITALY CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Cancer Vaccines Sales and Value (2012-2017)
  10.1.1 Italy Cancer Vaccines Sales and Growth Rate (2012-2017)
  10.1.2 Italy Cancer Vaccines Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Cancer Vaccines Sales Price Trend (2012-2017)
10.2 Italy Cancer Vaccines Sales and Market Share by Manufacturers
10.3 Italy Cancer Vaccines Sales and Market Share by Type
10.4 Italy Cancer Vaccines Sales and Market Share by Application

11 SPAIN CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Cancer Vaccines Sales and Value (2012-2017)
  11.1.1 Spain Cancer Vaccines Sales and Growth Rate (2012-2017)
  11.1.2 Spain Cancer Vaccines Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Cancer Vaccines Sales Price Trend (2012-2017)
11.2 Spain Cancer Vaccines Sales and Market Share by Manufacturers
11.3 Spain Cancer Vaccines Sales and Market Share by Type
11.4 Spain Cancer Vaccines Sales and Market Share by Application

12 BENELUX CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Cancer Vaccines Sales and Value (2012-2017)
  12.1.1 Benelux Cancer Vaccines Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Cancer Vaccines Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Cancer Vaccines Sales Price Trend (2012-2017)
12.2 Benelux Cancer Vaccines Sales and Market Share by Manufacturers
12.3 Benelux Cancer Vaccines Sales and Market Share by Type
12.4 Benelux Cancer Vaccines Sales and Market Share by Application

13 EUROPE CANCER VACCINES MANUFACTURERS ANALYSIS

13.1 Dendreon
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 GlaxoSmithKline
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Merck
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Sanofi
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Vaccinogen
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Vaxon Biotech
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Vical
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Aduro BioTech
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Advantagene
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE CANCER VACCINES MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Cancer Vaccines Market Forecast by Type (2017-2022)
15.9 Europe Cancer Vaccines Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGUES

Figure Picture of Cancer Vaccines
Table Classification of Cancer Vaccines
Figure Europe Sales Market Share of Cancer Vaccines by Type in 2016
Table Application of Cancer Vaccines
Figure Europe Sales Market Share of Cancer Vaccines by Application in 2016
Figure Germany Cancer Vaccines Revenue and Growth Rate (2012-2022)
Figure France Cancer Vaccines Revenue and Growth Rate (2012-2022)
Figure UK Cancer Vaccines Revenue and Growth Rate (2012-2022)
Figure Russia Cancer Vaccines Revenue and Growth Rate (2012-2022)
Figure Italy Cancer Vaccines Revenue and Growth Rate (2012-2022)
Figure Spain Cancer Vaccines Revenue and Growth Rate (2012-2022)
Figure Benelux Cancer Vaccines Revenue and Growth Rate (2012-2022)
Figure Europe Cancer Vaccines Sales and Growth Rate (2012-2022)
Figure Europe Cancer Vaccines Revenue and Growth Rate (2012-2022)
Table Europe Cancer Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Cancer Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Vaccines Sales Share by Manufacturers
Figure 2016 Cancer Vaccines Sales Share by Manufacturers
Table Europe Cancer Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Cancer Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cancer Vaccines Revenue Share by Manufacturers
Table 2016 Europe Cancer Vaccines Revenue Share by Manufacturers
Table Europe Cancer Vaccines Sales and Market Share by Type (2012-2017)
Table Europe Cancer Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Vaccines by Type (2012-2017)
Figure Europe Cancer Vaccines Sales Growth Rate by Type (2012-2017)
Table Europe Cancer Vaccines Revenue and Market Share by Type (2012-2017)
Table Europe Cancer Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Vaccines by Type (2012-2017)
Figure Europe Cancer Vaccines Revenue Growth Rate by Type (2012-2017)
Table Europe Cancer Vaccines Sales and Market Share by Countries (2012-2017)
Table Europe Cancer Vaccines Sales Share by Countries (2012-2017)
Figure Sales Market Share of Cancer Vaccines by Countries (2012-2017)
Table Europe Cancer Vaccines Revenue and Market Share by Countries (2012-2017)
Table Europe Cancer Vaccines Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Cancer Vaccines by Countries (2012-2017)
Table Europe Cancer Vaccines Sales and Market Share by Application (2012-2017)
Table Europe Cancer Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Cancer Vaccines by Application (2012-2017)
Figure Germany Cancer Vaccines Sales and Growth Rate (2012-2017)
Figure Germany Cancer Vaccines Revenue and Growth Rate (2012-2017)
Figure Germany Cancer Vaccines Sales Price Trend (2012-2017)
Table Germany Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Cancer Vaccines Sales by Type (2015 and 2016)
Table Germany Cancer Vaccines Market Share by Type (2015 and 2016)
Table Germany Cancer Vaccines Sales by Application (2015 and 2016)
Table Germany Cancer Vaccines Market Share by Application (2015 and 2016)
Figure France Cancer Vaccines Sales and Growth Rate (2012-2017)
Figure France Cancer Vaccines Revenue and Growth Rate (2012-2017)
Figure France Cancer Vaccines Sales Price Trend (2012-2017)
Table France Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table France Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Cancer Vaccines Sales by Type (2015 and 2016)
Table France Cancer Vaccines Market Share by Type (2015 and 2016)
Table France Cancer Vaccines Sales by Application (2015 and 2016)
Table France Cancer Vaccines Market Share by Application (2015 and 2016)
Figure UK Cancer Vaccines Sales and Growth Rate (2012-2017)
Figure UK Cancer Vaccines Revenue and Growth Rate (2012-2017)
Figure UK Cancer Vaccines Sales Price Trend (2012-2017)
Table UK Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Cancer Vaccines Sales by Type (2015 and 2016)
Table UK Cancer Vaccines Market Share by Type (2015 and 2016)
Table UK Cancer Vaccines Sales by Application (2015 and 2016)
Table UK Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Russia Cancer Vaccines Sales and Growth Rate (2012-2017)
Figure Russia Cancer Vaccines Revenue and Growth Rate (2012-2017)
Figure Russia Cancer Vaccines Sales Price Trend (2012-2017)
Table Russia Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Cancer Vaccines Sales by Type (2015 and 2016)
Table Russia Cancer Vaccines Market Share by Type (2015 and 2016)
Table Russia Cancer Vaccines Sales by Application (2015 and 2016)
Table Russia Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Italy Cancer Vaccines Sales and Growth Rate (2012-2017)
Figure Italy Cancer Vaccines Revenue and Growth Rate (2012-2017)
Figure Italy Cancer Vaccines Sales Price Trend (2012-2017)
Table Italy Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Cancer Vaccines Sales by Type (2015 and 2016)
Table Italy Cancer Vaccines Market Share by Type (2015 and 2016)
Table Italy Cancer Vaccines Sales by Application (2015 and 2016)
Table Italy Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Spain Cancer Vaccines Sales and Growth Rate (2012-2017)
Figure Spain Cancer Vaccines Revenue and Growth Rate (2012-2017)
Figure Spain Cancer Vaccines Sales Price Trend (2012-2017)
Table Spain Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Cancer Vaccines Sales by Type (2015 and 2016)
Table Spain Cancer Vaccines Market Share by Type (2015 and 2016)
Table Spain Cancer Vaccines Sales by Application (2015 and 2016)
Table Spain Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Cancer Vaccines Sales and Growth Rate (2012-2017)
Figure Benelux Cancer Vaccines Revenue and Growth Rate (2012-2017)
Figure Benelux Cancer Vaccines Sales Price Trend (2012-2017)
Table Benelux Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Cancer Vaccines Sales by Type (2015 and 2016)
Table Benelux Cancer Vaccines Market Share by Type (2015 and 2016)
Table Benelux Cancer Vaccines Sales by Application (2015 and 2016)
Table Benelux Cancer Vaccines Market Share by Application (2015 and 2016)
Table Dendreon Basic Information List
Table Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dendreon Cancer Vaccines Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Cancer Vaccines Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Cancer Vaccines Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Cancer Vaccines Sales Market Share (2012-2017)
Table Vaccinogen Basic Information List
Table Vaccinogen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Vaccinogen Cancer Vaccines Sales Market Share (2012-2017)
Table Vaxon Biotech Basic Information List
Table Vaxon Biotech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Vaxon Biotech Cancer Vaccines Sales Market Share (2012-2017)
Table Vical Basic Information List
Table Vical Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Vical Cancer Vaccines Sales Market Share (2012-2017)
Table Aduro BioTech Basic Information List
Table Aduro BioTech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Aduro BioTech Cancer Vaccines Sales Market Share (2012-2017)
Table Advantagene Basic Information List
Table Advantagene Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Advantagene Cancer Vaccines Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Vaccines
Figure Manufacturing Process Analysis of Cancer Vaccines
Figure Cancer Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2016
Table Major Buyers of Cancer Vaccines
Table Distributors/Traders List
Figure Germany Cancer Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure Germany Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure France Cancer Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure France Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure UK Cancer Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure UK Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Cancer Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure Russia Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Cancer Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure Italy Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Cancer Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure Spain Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Cancer Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
Table Europe Cancer Vaccines Sales Forecast by Type (2017-2022)
Table Europe Cancer Vaccines Sales Forecast by Application (2017-2022)